荧光免疫分析市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00011093
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 194
Buy Now

2021年荧光免疫分析市场价值为25.7866亿美元,预计到2028年将达到37.7878亿美元;预计 2021 年至 2028 年复合年增长率为 5.6%。

荧光免疫分析只是免疫分析的一种不同类型。关键变量是用于检测“检测器”抗体和分析物分子结合的生化技术。荧光免疫分析是一种灵敏的技术,可以测量许多化合物,包括药物、激素和蛋白质;识别抗体;并量化抗原,例如病毒颗粒和可能的细菌。荧光检测系统包括更高灵敏度的分析物检测、简化的试剂和更简单的测定设计。近年来取得了多项突破,使得基于荧光的免疫分析系统能够在护理点使用。最近发生的几项技术改进使得易受影响的免疫测定系统得以实施。其中包括窄波长、低成本光源、具有广泛斯托克斯位移的更新、更稳定的荧光团、稳定的固态光探测器以及用于处理和分析每次测试数据的微处理器。当荧光检测系统连接到侧流检测并与功能强大但价格低廉的分析仪结合使用时,可以提高检测性能。

战略见解

范围全球荧光免疫分析市场包括产品类型、应用、最终用户和地理位置。根据北美、欧洲、亚太地区、中东和美国等地区对荧光免疫分析市场进行了分析。非洲、南美和非洲中美洲。该报告提供了对荧光免疫分析市场的见解和深入分析,强调了各种参数,例如市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争格局分析。

利润丰厚荧光免疫分析市场区域


市场洞察
全球慢性病患病率不断上升。

慢性疾病和病症正在上升全世界。对昂贵的慢性病护理的需求不断增加,对医疗保健系统提出了巨大的要求。据美国疾病控制与预防中心 (CDC) 统计,截至 2016 年,估计有 1.5 亿美国人患有一种或多种慢性病。据世界卫生组织 (WHO) 统计,慢性病患病率预计将增加 57% 2020 年。根据国家生物技术信息中心 (NCBI) 的数据,慢性肾病 (CKD) 是全球第 14 大死因,每年导致 120 万人死亡。早期发现和治疗至关重要,因为进行性 CKD 与不幸的临床后果相关,包括终末期肾病 (ESKD)、心血管疾病和死亡率增加。慢性肾脏病的诊断、预后和控制基于对肾小球滤过率 (GFR) 的了解。胱抑素-C 是比常用的肌酐更好的 GFR 标记物。开发并优化了荧光侧流免疫测定法,以估计半胱氨酸蛋白酶抑制剂 C 值,从而计算肾小球滤过率。

COVID-19 大流行凸显了在护理点进行快速、准确的核酸检测的必要性。基于荧光的定量逆转录PCR (RT-qPCR) 具有高灵敏度和特异性。此外,大多数感染 SARS-CoV-2 的人会出现轻微症状或无症状。因此,迫切需要开发快速、简单和高通量的核酸检测方法。标准荧光免疫分析系统是一种多参数、随机访问系统,可提供准确可靠的诊断结果。它是一个能够对感染、呼吸道疾病和慢性疾病进行定性和定量分析的系统。截止指数为医疗决策提供了良好的参考点。因此,COVID-19 病例发病率的上升和慢性疾病的增加是全球荧光免疫分析市场增长的原因。

基于产品类型的见解

根据产品类型,市场是分为 ELISA、快速侧流免疫分析等。 2021年,ELISA细分市场占据最大市场份额。 ELISA 是一种基于板的测试技术,用于检测和测量可溶性分子,如肽、蛋白质、抗体和激素。该细分市场的增长归因于免疫分析测试在诊断癌症、传染病和其他慢性问题方面的大量使用。在预测期内,同一细分市场可能会在全球荧光免疫分析市场中实现最高的复合年增长率。

全球荧光免疫分析市场,按应用划分 – 2021 年及2028


基于应用的见解

根据应用,全球荧光免疫分析市场分为传染病、肿瘤、心血管疾病等。传染病细分市场在 2021 年占据最大市场份额,预计该细分市场在预测期内的复合年增长率最高。

最终用户 –基于洞察

就最终用户而言,全球荧光免疫分析市场分为医院和医院。诊所、诊断中心、制药和医疗中心生物技术公司、学术界和研究机构等。医院和医院诊所细分市场在 2021 年占据最大市场份额,预计该细分市场在预测期内将实现最高的复合年增长率。

COVID-19 大流行已成为整个行业面临的最重大挑战世界。这一挑战令人恐惧,尤其是在全球发展中国家,因为全球贸易中断导致进口减少。迄今为止,尚未确定针对 COVID-19 的明确治疗方法。因此,缺乏明确的治疗方法为全球荧光免疫分析市场提供了重大机遇。从长远来看,荧光免疫分析市场将具有显着的增长前景,因为许多市场参与者的新开发测试已获得紧急使用授权。 2020年5月,ERBA Diagnostics Mannheim GmbH(德国)推出了基于免疫分析的试剂盒——ErbaLisa COVID-19 ELISA试剂盒,用于检测针对SARS-CoV-2的IgG和IgM抗体。此外,研究人员还开发了适合家庭使用的便携式设备、试剂和标准品。因此,所有这些发展都会增加对荧光免疫分析的未来需求的激增。

公司通常采用产品发布和扩张策略来扩大其在全球的足迹并满足不断增长的需求。市场参与者通常采用这些策略来扩大其产品组合。

全球荧光免疫分析市场的市场参与者采用产品创新策略来满足全球不断变化的客户需求,这也使得

  • 2021 年 6 月,F. Hoffmann-La Roche Ltd. 宣布推出高通量 SARS-CoV-2 抗原测试,以帮助SARS-CoV-2 感染的诊断。基于实验室的 Elecsys SARS-CoV-2 抗原检测早前获得了 CE 标志,并于最近获得了 CDSCO 的进口许可证。
  • 2021 年 5 月,配备 BD Trucount 管的 BD Multitest 6 色 TBNK 试剂旨在帮助临床医生确定 COVID-19 患者机械通气插管的风险和死亡率,从而协助住院患者的管理决策。带有可选 BD Trucount 管的 BD Multitest 6 色 TBNK 试剂已获得加拿大卫生部许可,作为 6 色直接免疫荧光试剂,可与适当配备的 BD 流式细胞仪一起使用,以识别和确定 T、B 和 T 细胞的百分比和绝对计数。自然杀伤 (NK) 细胞,以及外周血中 T 细胞的 CD4 和 CD8 亚群。带有 BD Trucount 管的 BD Multitest 6 色 TBNK 试剂可与 BD FACS Loader 和 BD FACS Universal Loader 一起使用。
  • 2021 年 5 月,Ortho Clinical Diagnostics 宣布其定量 COVID-19 IgG 抗体测试获得了 CE 标志。 Ortho 的 VITROS 抗 SARS-CoV-2 IgG 定量抗体测试可追溯到 WHO 抗 SARS-CoV-2 IgG 抗体国际标准,该标准的制定是为了促进 SARS-CoV-2 血清学方法的标准化。< /li>
  • 2020 年 12 月,贝克曼库尔特宣布推出一项新测试,通过大规模 COVID-19 测试的推出,解决学校、企业、医院和社区目前面临的三个主要障碍。新的 Access SARS-CoV-2 抗原检测提供了高质量、高通量的 COVID-19 检测,其检测量、工作流程和可扩展的灵活性有助于对抗 COVID-19 大流行。 Access SARS-CoV-2 抗原检测以 4 美元的价格向医疗保健提供者提供,使可靠且频繁的大规模检测变得负担得起。

荧光免疫分析 –市场细分

全球荧光免疫分析市场根据产品类型、应用和最终用户进行细分。根据产品类型,荧光免疫分析市场进一步细分为 ELISA、快速侧流免疫分析等。从应用来看,荧光免疫分析市场进一步细分为传染病、肿瘤、心血管疾病等。根据最终用户,荧光免疫分析市场分为医院和医院。诊所、诊断中心、制药和医疗中心生物技术公司、学术界和研究机构等。按地域划分,全球荧光免疫分析市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、印度、日本、澳大利亚、韩国和亚太地区其他地区)、中东和美国非洲(沙特阿拉伯、阿联酋、南非和中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

公司简介

  • Abbott
  • BD
  • 生物梅里埃公司
  • F. Hoffman-La Roche Ltd.
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Quidel Corp.
  • >
  • Ortho Clinical Diagnostics Holdings plc
  • 丹纳赫
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which product type held the largest share in the market?

The ELISA segment dominated the global fluorescent immunoassay market and held the largest market share of 56.12% in 2021.

Which application held the largest share in the market?

The infectious diseases segment dominated the global fluorescent immunoassay market and held the largest market share of 54.39% in 2021.

Which end user held the largest share in the market?

The hospitals & clinics segment dominated the global fluorescent immunoassay market and held the largest market share of 43.16% in 2021.

Who are the major players in the Fluorescent Immunoassay market?

The fluorescent immunoassay market majorly consists of the players such as Abbott, BD, bioMerieux SA, F. Hoffman-La Roche Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Quidel Corp., Ortho Clinical Diagnostics Holdings plc, Danaher and among others.

What are the driving factors for the fluorescent immunoassay market across the globe?

The factors that are driving the growth of the market are the growing prevalence of chronic diseases and increasing demand for cell therapies are expected to boost the growth of the global fluorescent immunoassay market.

What is fluorescent immunoassay?

Fluorescence immunoassay is a sensitive technique that is used in the measurement of many compounds, including drugs, hormones, and proteins; in the identification of antibodies; and in the quantification of antigens such as viral particles and, potentially, bacteria. The fluorescence detection system includes higher sensitivity detection of the analyte, simplified reagents, and simpler assay designs. A modern fluorescent-based immunoassay uses as the detection reagent a fluorescent compound that absorbs light or energy (excitation energy) at a specific wavelength and then emits light or energy at a different wavelength.

The List of Companies - Fluorescent Immunoassay Market

  1. Thermo Fisher Scientific
  2. Abbott Laboratories
  3. Ortho Clinical Diagnostics
  4. BD
  5. F. Hoffmann La Roche
  6. Danaher
  7. bioMérieux SA
  8. Siemens AG
  9. Sysmex
  10. Quidel Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports